Sirolimusformulierung

European patent · EP1982702 · In force

Register entry

Publication number
EP1982702
Application number
EP08150504
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 22, 2008
Published
Oct 22, 2008
Granted
Mar 27, 2013
Protection ends at the latest
Jan 21, 2028
Next annual fee due
Jan 31, 2027
IPC classes
A61K 9/28 (2006.01)
A61K 9/48 (2006.01)
A61K 31/435 (2006.01)
A61K 47/14 (2006.01)
Priority
EP 07101079 24.01.2007
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  2. Feb 1, 2025

    Change

    Published in Swissreg on 01.02.2025

  3. Feb 1, 2024

    Change

    Published in Swissreg on 01.02.2024

  4. Feb 1, 2023

    Change

    Published in Swissreg on 01.02.2023

  5. Mar 27, 2013

    Granted

    Published in Swissreg on 27.03.2013

Parties

Holder

LEK Pharmaceuticals d.d.

Verovskova 57, 1526 Ljubljana, SI

Inventor

Reven, Sebastjan

4270, Jesenice, SI

Legen, Igor

1290, Grosuplje, SI

Jerala-Strukelj Zdenka

4211, Mavcice, SI

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.